ArticleMikrochimica acta2025
β-cyclodextrin-modified silver nanoparticles for highly selective recognition of chiral Trp and its mechanism.
Article in Mikrochimica acta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Chiral recognition plays a crucial role in the fields of chemistry, biomedicine, and food science. In this study, β-cyclodextrin-modified silver nanoparticles (β-CD@AgNPs) with enhanced chiral binding ability were successfully prepared using the reduction method and utilized for the selective recognition of tryptophan (Trp) enantiomers, one of the representatives of non-polar amino acids. Interestingly, the β-CD@AgNPs with L-Trp system exhibited a red color (with a new ultraviolet-visible (UV-vis) absorption peak at around 550 nm), while no change occurred with D-Trp. Compared with unmodified silver nanoparticles (AgNPs), the recognition results of chiral Trp by β-CD@AgNPs were reversed. β-CD@AgNPs were also used to recognize non-polar (phenylalanine (Phe), valine (Val) and leucine (Leu)), polar (tyrosine (Tyr) and serine (Ser)), and basic (histidine (His)) and acidic (aspartic acid (Asp)) amino acids, respectively. It was found that β-CD@AgNPs demonstrated high selectivity only for Trp among non-polar amino acids. Furthermore, the recognition mechanism was studied through calculations, and it indicated that the binding energy strength between L-Trp and β-CD@AgNPs (-2540.76 kcal/mol) was higher than that between D-Trp and β-CD@AgNPs (-2326.91 kcal/mol). Owing to the significant electronegativity of the β-CD cavity, the indole ring of L-Trp exhibited susceptibility to electrostatic interactions, leading to enhanced adsorption within the β-CD cavity. This effect consequently improved the aggregation capability of the β-CD@AgNPs. Finally, β-CD@AgNPs were used for determining the enantiomeric excess (ee%) of Trp. A favorable linear relationship between the UV-vis absorption intensity and the ee% of Trp was established (R
Indexed as
Identifiers
40353901What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.